This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Canaccord Genuity analyst Joseph Vafi downgraded the rating for ASGN Incorporated ASGN from Buy to Hold and lowered the price target from $115 to $55. ASGN shares closed at $51.76 on Thursday. See how other analysts view this stock.
JP Morgan analyst Alexei Gogolev downgraded SS&C Technologies Holdings, Inc. SSNC from Overweight to Neutral and lowered the price target from $90 to $86. SS&C Technologies shares closed at $77.43 on Thursday. See how other analysts view this stock.
Macquarie analyst Linda Huang downgraded the rating for TAL Education Group TAL from Outperform to Neutral and cut the price target from $14.5 to $10.9. TAL Education shares closed at $8.93 on Thursday. See how other analysts view this stock.
Wells Fargo analyst Tiago Fauth downgraded United Therapeutics Corporation UTHR from Overweight to Equal-Weight and slashed the price target from $395 to $314. United Therapeutics shares closed at $296.42 on Thursday. See how other analysts view this stock.

Considering buying UTHR stock? Here’s what analysts think:

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.